Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structural Protein Function01:56

Structural Protein Function

29.9K
Structural proteins are a category of proteins responsible for functions ranging from cell shape and movement to providing support to major structures such as bones, cartilage, hair, and muscles. This group includes proteins such as collagen, actin, myosin, and keratin.
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity.  In bones and teeth, it mineralizes to...
29.9K
Structural Protein Function01:56

Structural Protein Function

3.3K
3.3K
Fruit Development, Structure, and Function01:58

Fruit Development, Structure, and Function

25.2K
Fruits form from a mature flower ovary. As seeds develop from the ovules contained within, the ovary wall undergoes a series of complex changes to form fruit. In some fruits, such as soybeans, the ovary wall dries; in other fruits, such as grapes, it remains fleshy. In some cases, organs other than the ovary contribute to fruit formation; such fruits are called accessory fruits.
25.2K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Structure and Function of Erythrocytes01:29

Structure and Function of Erythrocytes

5.8K
There are between 4.2 and 6 million erythrocytes, also known as red blood cells, in every microliter of blood. These cells are small, flattened biconcave discs with centers that are depressed.
The erythrocyte plasma membrane is associated with proteins such as spectrin, which forms a flexible cytoplasmic meshwork. This meshwork allows erythrocytes to twist, turn, become cup-shaped, and regain their biconcave shape as they pass through narrow capillaries. Additionally, erythrocytes can form...
5.8K
Structure and Function of Platelets01:18

Structure and Function of Platelets

3.5K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hybrid Nanoporous Gold-Cyclodextrin Nanosponge Platforms for Enhanced Model Contaminant Detection.

ACS applied polymer materials·2026
Same author

Synthesis of Hydrophobic Derivatives of Stilbenes with Improved Permeability and Limited Phase II Reactions.

Journal of agricultural and food chemistry·2026
Same author

Correction: Tonon et al. 5-Azacytidine Downregulates the Proliferation and Migration of Hepatocellular Carcinoma Cells In Vitro and In Vivo by Targeting miR-139-5p/ROCK2 Pathway. <i>Cancers</i> 2022, <i>14</i>, 1630.

Cancers·2026
Same author

Red and Far-Red LED Lighting Enhances Protoplast-to-Plant Regeneration in Broccoli (<i>Brassica oleracea</i> var. <i>italica</i>).

Plants (Basel, Switzerland)·2026
Same author

pH-Sensitive Dextrin-Based Nanosponges Crosslinked with Pyromellitic Dianhydride and Citric Acid: Swelling, Rheological Behavior, Mucoadhesion, and In Vitro Drug Release.

Gels (Basel, Switzerland)·2026
Same author

Redox responsive cyclodextrin-based drug delivery systems: a special insight to glutathione responsive CD-nanosponges.

Expert opinion on drug delivery·2026

Related Experiment Video

Updated: Jan 29, 2026

Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web
09:51

Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web

Published on: July 16, 2017

16.0K

Trends in Inhibitors, Structural Modifications, and Structure-Function Relationships of Phosphodiesterase 4: A

Antonio Sánchez-Belmonte1, Adrián Matencio1, Irene Conesa1

  • 1Departamento de Bioquímica y Biología Molecular A, Unidad Docente de Biología, Facultad de Veterinaria, Regional Campus of International Excellence "Campus Mare Nostrum", Universidad de Murcia, 30100 Murcia, Spain.

Biomolecules
|January 28, 2026
PubMed
Summary

Phosphodiesterase 4 (PDE4) enzyme regulates inflammation. Natural compounds offer safer, selective PDE4 inhibitors by leveraging structural insights, overcoming limitations of current synthetic drugs.

Keywords:
PDE4cAMPnatural inhibitorsrational drug designselectivitystructural biology

More Related Videos

Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship
08:25

Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship

Published on: January 8, 2019

9.9K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.2K

Related Experiment Videos

Last Updated: Jan 29, 2026

Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web
09:51

Investigating Protein Sequence-structure-dynamics Relationships with Bio3D-web

Published on: July 16, 2017

16.0K
Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship
08:25

Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship

Published on: January 8, 2019

9.9K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.2K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Structural Biology

Background:

  • Phosphodiesterase 4 (PDE4) hydrolyzes cyclic adenosine monophosphate (cAMP), regulating inflammatory and immune signaling pathways.
  • PDE4 isoform structural conservation and subtle variations influence selectivity and tissue distribution.
  • Current synthetic PDE4 inhibitors (e.g., roflumilast) face dose-dependent adverse effects due to lack of isoform selectivity.

Purpose of the Study:

  • To explore natural products as scaffolds for developing safer, isoform-selective PDE4 inhibitors.
  • To leverage structural insights for rational drug design targeting PDE4.
  • To address limitations of current synthetic PDE4 inhibitors.

Main Methods:

  • Analysis of structural features of PDE4 catalytic domains.
  • Investigation of natural products (flavonoids, terpenoids, polyphenols) as potential PDE4 inhibitors.
  • Integration of crystallographic and computational studies with natural compound optimization.

Main Results:

  • Natural products like curcumin and α-mangostin show promise as molecular scaffolds.
  • Structural diversity of natural compounds allows for fine-tuning of potency and selectivity.
  • Rational modification of natural compounds can lead to improved PDE4 inhibitor profiles.

Conclusions:

  • Natural products offer a viable alternative to synthetic inhibitors with potentially lower toxicity and better biocompatibility.
  • Integrating structural biology with natural product chemistry is a promising strategy for developing next-generation PDE4 therapies.
  • Targeting PDE4 isoforms selectively can mitigate adverse effects and enhance therapeutic outcomes.